Advanced Biomed Inc. (ADVB)

Market Cap	10.54M +4.4%
Revenue (ttm)	n/a
Net Income	5.28M
EPS	4.67
Shares Out	1.65M
PE Ratio	1.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,399
Open	6.53
Previous Close	6.47
Day's Range	6.38 - 6.77
52-Week Range	3.61 - 24.23
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 7, 2026

About ADVB

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunost...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Mar 6, 2025
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: ADVB
• Website: https://www.advanbiomed.com

Financial Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 23, 2026

Data Sources Report a data error